1016 related articles for article (PubMed ID: 14613268)
1. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
[TBL] [Abstract][Full Text] [Related]
2. Anaemia of chronic disease in AA amyloidosis is associated with allele 2 of the interleukin-1beta-511 promoter gene and raised levels of interleukin-1beta and interleukin-18.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
J Intern Med; 2004 Aug; 256(2):145-52. PubMed ID: 15257727
[TBL] [Abstract][Full Text] [Related]
3. Association between the level of circulating bioactive tumor necrosis factor alpha and the tumor necrosis factor alpha gene polymorphism at -308 in patients with rheumatoid arthritis treated with a tumor necrosis factor alpha inhibitor.
Marotte H; Arnaud B; Diasparra J; Zrioual S; Miossec P
Arthritis Rheum; 2008 May; 58(5):1258-63. PubMed ID: 18438841
[TBL] [Abstract][Full Text] [Related]
4. Circulating TNFRI and TNFRII levels correlated with the disease activity score (DAS28) in rheumatoid arthritis.
Valle Y; Ledezma-Lozano IY; Torres-Carrillo N; Padilla-Gutiérrez JR; Navarro-Hernández RE; Vázquez-Del Mercado M; Palafox-Sánchez CA; Armendáriz-Borunda J; Muñoz-Valle JF
Scand J Rheumatol; 2009; 38(5):332-5. PubMed ID: 19579138
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
Glossop JR; Dawes PT; Nixon NB; Mattey DL
Arthritis Res Ther; 2005; 7(6):R1227-34. PubMed ID: 16277675
[TBL] [Abstract][Full Text] [Related]
7. No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis.
Glossop JR; Nixon NB; Dawes PT; Hassell AB; Mattey DL
J Rheumatol; 2003 Jul; 30(7):1406-9. PubMed ID: 12858434
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor alpha 5'-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis.
Shibue T; Tsuchiya N; Komata T; Matsushita M; Shiota M; Ohashi J; Wakui M; Matsuta K; Tokunaga K
Arthritis Rheum; 2000 Apr; 43(4):753-7. PubMed ID: 10765919
[TBL] [Abstract][Full Text] [Related]
9. [Tumor necrosis factor-alpha and kidney damage in rheumatoid arthritis].
Tsybul'ko SV; Baranov AA; Borodin AG; Korshunov NI; Kirdianov SIu
Ter Arkh; 2001; 73(5):8-11. PubMed ID: 11517757
[TBL] [Abstract][Full Text] [Related]
10. TNF-alpha -308 promoter polymorphism in patients with rheumatoid arthritis.
Pawlik A; Florczak M; Ostanek L; Brzosko M; Brzosko I; Szklarz BG
Scand J Rheumatol; 2005; 34(1):22-6. PubMed ID: 15903021
[TBL] [Abstract][Full Text] [Related]
11. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
Robak T; Gladalska A; Stepień H
Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
[TBL] [Abstract][Full Text] [Related]
12. Raised circulating interleukin-18 levels in reactive AA-amyloidosis.
Maury CP; Tiitinen S; Laiho K; Kaarela K; Liljeström M
Amyloid; 2002 Jun; 9(2):141-4. PubMed ID: 12440487
[TBL] [Abstract][Full Text] [Related]
13. Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes.
Glossop JR; Dawes PT; Hassell AB; Mattey DL
J Rheumatol; 2005 Sep; 32(9):1673-8. PubMed ID: 16142859
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis.
Fabris M; Tolusso B; Di Poi E; Assaloni R; Sinigaglia L; Ferraccioli G
J Rheumatol; 2002 Sep; 29(9):1847-50. PubMed ID: 12233877
[TBL] [Abstract][Full Text] [Related]
15. Hemoglobin levels correlate with serum soluble CD23 and TNF-Rs concentrations in patients with rheumatoid arthritis.
Vaiopoulos G; Boki K; Kapsimali V; Coulocheri S; Papadaki HA; Eliopoulos GD
Haematologia (Budap); 1998; 29(2):89-99. PubMed ID: 9728801
[TBL] [Abstract][Full Text] [Related]
16. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes.
Cvetkovic JT; Wallberg-Jonsson S; Stegmayr B; Rantapaa-Dahlqvist S; Lefvert AK
J Rheumatol; 2002 Feb; 29(2):212-9. PubMed ID: 11838837
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor-alpha (TNF-alpha) levels and influence of -308 TNF-alpha promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis.
Cuchacovich M; Ferreira L; Aliste M; Soto L; Cuenca J; Cruzat A; Gatica H; Schiattino I; Pérez C; Aguirre A; Salazar-Onfray F; Aguillón JC
Scand J Rheumatol; 2004; 33(4):228-32. PubMed ID: 15370717
[TBL] [Abstract][Full Text] [Related]
19. Genetic contribution of tumor necrosis factor (TNF)-alpha gene promoter (-1031, -863 and -857) and TNF receptor 2 gene polymorphisms in endometriosis susceptibility.
Teramoto M; Kitawaki J; Koshiba H; Kitaoka Y; Obayashi H; Hasegawa G; Nakamura N; Yoshikawa T; Matsushita M; Maruya E; Saji H; Ohta M; Honjo H
Am J Reprod Immunol; 2004 May; 51(5):352-7. PubMed ID: 15212671
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]